(1)
Formulation and Characterization of Imatinib Mesylate Liposomes in Gel for Intraarticular Administration. Int. J. Pharm. Sci. Drug Res. 2022, 14 (5), 559-566. https://doi.org/10.25004/IJPSDR.2022.140508.